Key result
Visceral adipose tissue volume at L3 (VATV L3) was independently associated with the presence of T2DM (OR 1.01, P=0.01), outperforming hepatic and pancreatic fat fractions as a predictor.
Why the study?
The study investigated the roles of MRI-quantified visceral adipose tissue volume, hepatic PDFF, and pancreatic PDFF in predicting the presence of type 2 diabetes mellitus across patients with T2DM, prediabetes, and normal glucose tolerance.
Does MRI quantitation of visceral abdominal adiposity tissue volume and PDFF predict the presence of type 2 diabetes mellitus?
Observational
Does MRI quantitation of visceral abdominal adiposity tissue volume and PDFF predict the presence of type 2 diabetes mellitus?
Odds Ratio: 1.01
p-value: p=0.01
MRI-quantified visceral adipose tissue volume at the L3 level is an independent predictor of type 2 diabetes mellitus, outperforming hepatic and pancreatic fat fractions.
No takes yet. Share an insight, caveat, or question.
May inform T2DM risk assessment via L3 VAT volume on MRI; leaves open incremental value and prospective validation.
Wang et al. (2019) conducted an observational in Type 2 diabetes mellitus. Visceral adipose tissue volume (VATV L3) vs. Normal glucose tolerance and prediabetes was evaluated on Presence of T2DM (OR 1.01, p=0.01). Visceral adipose tissue volume at L3 (VATV L3) was independently associated with the presence of T2DM (OR 1.01, P=0.01), outperforming hepatic and pancreatic fat fractions as a predictor.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: